Ticker keeps hitting new highs and is in the rapid testing via saliva CV-19 testing. Looks like a winner from here imo. FDA approval for in-home test news any day now imo.
-The diagnostic test company said it plans to file for FDA Emergency Use Authorization allowing for an in-home self-test to debut into the U.S. market.
-OraSure said its portable rapid test platform uses an oral fluid sample and provides results in 20 minutes, with no instrumentation or trained personnel needed to administer the test or read the results.
-Co announced it has been awarded a $710,310 contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services (HHS), to develop a pan-SARS-coronavirus antigen rapid in-home self-test that uses oral fluid samples. This support from BARDA will enable OraSure to file for FDA Emergency Use Authorization (EUA) allowing for an in-home self-test to debut into the U.S. market.
Market Data 
Markets 
AI
